Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms
ABSTRACTIntroduction Risk stratification is essential for treatment decision in myelodysplastic neoplasms (MDS). Molecular international prognostic scoring system (M-IPSS) has been recently developed combining somatic mutations and clinical information being used in the revised international prognos...
Main Authors: | Chantana Polprasert, Pimjai Niparuck, Thanawat Rattanathammethee, Sirorat Kobbuaklee, Theerin Lanamtieng, Ponlapat Rojnuckarin |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | Hematology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2022.2156682 |
Similar Items
-
Elevated mature monocytes in bone marrow accompanied with a higher IPSS-R score predicts a poor prognosis in myelodysplastic syndromes
by: An Wu, et al.
Published: (2021-05-01) -
Impact of IPSS-M implementation in real-life clinical practice
by: Irene Zamanillo, et al.
Published: (2023-05-01) -
The AST/ALT (De Ritis) ratio as a significant prognostic factor in myelodysplastic syndrome
by: Ying Chen, et al.
Published: (2024-12-01) -
Converting between the International Prostate Symptom Score (IPSS) and the Expanded Prostate Cancer Index Composite (EPIC) urinary subscales: modeling and external validation
by: Paul Windisch, et al.
Published: (2024-02-01) -
Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome
by: Bruno Deltreggia Benites, et al.
Published: (2013-01-01)